Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.

VOLUME 286 (2011) PAGES 1134–1146

This article has been retracted by the publisher. An investigation at MD Anderson determined that the image of medium control and the image of DR4+DR5 siRNA treated with TRAIL in Fig. 3B were reused.